CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
0.5800
-0.0558 (-8.78%)
At close: Apr 1, 2025, 4:00 PM
0.5890
+0.0090 (1.54%)
After-hours: Apr 1, 2025, 4:52 PM EDT
CytomX Therapeutics Employees
As of December 31, 2024, CytomX Therapeutics had 121 total employees, including 119 full-time and 2 part-time employees. The number of employees decreased by 1 or -0.82% compared to the previous year.
Employees
121
Change (1Y)
-1
Growth (1Y)
-0.82%
Revenue / Employee
$1,141,347
Profits / Employee
$263,380
Market Cap
46.46M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CTMX News
- 25 days ago - CytomX Therapeutics, Inc. (CTMX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 25 days ago - CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 27 days ago - CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - CytomX Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 - GlobeNewsWire
- 3 months ago - CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update - GlobeNewsWire
- 4 months ago - CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference - GlobeNewsWire
- 5 months ago - CytomX Therapeutics, Inc. (CTMX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire